enGene Holdings, Inc. (ENGN)
10.36
-0.26
(-2.45%)
USD |
NASDAQ |
Feb 20, 16:00
10.38
+0.02
(+0.14%)
After-Hours: 20:00
enGene Holdings EPS Diluted (Quarterly) : -0.7383 for Oct. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Aurinia Pharmaceuticals, Inc. | 0.232 |
| Achieve Life Sciences, Inc. | -0.2831 |
| Oncolytics Biotech, Inc. | -0.1032 |
| Edesa Biotech, Inc. | -0.2819 |
| Lexaria Bioscience Corp. | -0.0746 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -37.88M |
| Total Expenses (Quarterly) | 37.88M |
| Enterprise Value | 531.94M |
| Earnings Yield | -22.15% |
| Normalized Earnings Yield | -22.15 |